Terkko Navigator / Cardiology/ Feeds

DOES STUDY SUBJECT DIVERSITY INFLUENCE CARDIOLOGY RESEARCH SITE PERFORMANCE?: INSIGHTS FROM 2 U.S. NATIONAL CORONARY STENT REGISTRIES

Access to cardiac surgery centers for cardiac and non-cardiac hospitalizations in adolescents and adults with congenital heart defects- a descriptive case series study

Targeting the gut microbiome in coronary artery disease

Plasma trimethylamine N-oxide (TMAO) levels predict future risk of coronary artery disease in apparently healthy individuals in the EPIC-Norfolk Prospective Population Study

Cardiac transplantation outcomes in patients with amyloid cardiomyopathy

Comparison of 1-month Versus 12-month Dual Antiplatelet Therapy after Implantation of Drug-eluting Stents Guided by either Intravascular Ultrasound or Angiography in Patients with Acute Coronary Syndrome: Rationale and Design of Prospective, Multicen

Natriuretic Peptide Plasma Concentrations and Risk of Cardiovascular Versus Non-Cardiovascular Events in Heart Failure with Reduced Ejection Fraction Insights from the PARADIGM-HF and ATMOSPHERE Trials

Response to: The paradox of implantable cardioverter-defibrillator: When guidelines play against care improvement

The paradox of implantable cardioverter-defibrillator: When guidelines may play against care improvement

Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients undergoing percutaneous coronary intervention: a meta-analysis of individual patient data from five randomized trials

Modified Design of Stimulation Of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy in Non-responders, Previously Untreatable and High-Risk Upgrade Patients (SOLVE-CRT) Trial

Association between Ambient Air Pollution and County-Level Cardiovascular Mortality in the United States by Social Deprivation Index

Rationale and design for the study of rivaroxaban to reduce thrombotic events, hospitalization and death in outpatients with COVID-19: The PREVENT-HD study

Rivaroxaban versus Warfarin in Patients with Atrial Fibrillation Enrolled in Latin America: Insights from ROCKET AF

Interventional Cardiologists' Perceptions of Percutaneous Coronary Intervention Quality Measurement and Feedback

Percutaneous Coronary Intervention in Patients with Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction: Insights from the VA CART Program

Rationale and Design of the Pragmatic Randomized Trial of Icosapent Ethyl for High Cardiovascular Risk Adults (MITIGATE)

Prevalence of ideal cardiovascular health in young adults: A birth cohort from southern Brazil

Periodontal Disease, Atrial Fibrillation and Stroke

Impact of insurance status on ICD implantation practice patterns: Insights from the NCDR ICD registry

Red blood cell transfusion threshold and mortality in cardiac intensive care unit patients

Variation in use and dosing escalation of renin angiotensin system, mineralocorticoid receptor antagonist, angiotensin receptor neprilysin inhibitor and beta-blocker therapies in heart failure and reduced ejection fraction: Association of comorbiditi

Edoxaban versus Warfarin in Patients with Atrial Fibrillation in Relation to the Risk of Stroke: A Secondary Analysis of the ENGAGE AF-TIMI 48 Study

Bleeding Avoidance Strategies and Percutaneous Coronary Intervention Outcomes: A Ten-year Observation from a Japanese Multicenter Registry: Post-PCI Bleeding Avoidance and Outcomes

A randomized ablation-based atrial fibrillation rhythm control versus rate control trial in patients with heart failure and high burden atrial fibrillation: The RAFT-AF trial rationale and design

Rationale and design of the CLEAR-outcomes trial: Evaluating the effect of Bempedoic acid on cardiovascular events in patients with statin intolerance

Comparison of intravascular ultrasound-guided with angiography-guided double kissing crush stenting for patients with complex coronary bifurcation lesions: Rationale and design of a prospective, randomized, and multicenter DKCRUSH VIII trial

A feasibility study for CODE-MI: High-sensitivity cardiac troponin-Optimizing the diagnosis of acute myocardial infarction/injury in women

Late kidney injury after transcatheter aortic valve replacement

Association of gut-related metabolites with outcome in acute heart failure

African American-Caucasian American differences in aortic valve replacement in patients with severe aortic stenosis

Corrigendum to "Impact of creatinine clearance on clinical outcomes in elderly atrial fibrillation patients receiving apixaban: J-ELD AF Registry sub-analysis" [Am Heart J, 223 (2020), 23-33]

Extracorporeal life support in patients with acute myocardial infarction complicated by cardiogenic shock - Design and rationale of the ECLS-SHOCK trial

IMPACT OF TARED PULMONARY ARTERIAL HYPERTENSION THERAPY IN PATIENTS WITH COMBINED - AND PRE-CAPILLARY PULMONARY HYPERTENSION

Acute kidney injury after radial or femoral artery access in ST-segment elevation myocardial infarction: AKI-SAFARI

An immediate or early invasive strategy in non-ST-elevation acute coronary syndrome: The OPTIMA-2 randomized controlled trial

Growth differentiation factor-15 is a biomarker for all-cause mortality but less evident for cardiovascular outcomes: A prospective study

Risk markers of incident atrial fibrillation in patients with coronary heart disease

NT-proBNP level before primary PCI and risk of poor myocardial reperfusion: Insight from the On-TIME II trial

Expansion of transcatheter aortic valve replacement in the United States

Out-of-hospital cardiac arrest: A systematic review of current risk scores to predict survival

Effects of sodium-glucose cotransporter 1 and 2 inhibitors on cardiovascular and kidney outcomes in type 2 diabetes: A meta-analysis update

The role of cardiac testing with the 0/1-hour high-sensitivity cardiac troponin algorithm evaluating for acute myocardial infarction

Trends in health care resource use and expenditures in patients with newly diagnosed paroxysmal supraventricular tachycardia in the United States

Sociodemographic differences in utilization and outcomes for temporary cardiovascular mechanical support in the setting of cardiogenic shock

Patient-centered contrast thresholds to reduce acute kidney injury in high-risk patients undergoing percutaneous coronary intervention

Effects of canagliflozin on cardiovascular, renal, and safety outcomes in participants with type 2 diabetes and chronic kidney disease according to history of heart failure: Results from the CREDENCE trial

Non-warfarin oral anticoagulant copayments and adherence in atrial fibrillation: A population-based cohort study

Management of heart failure in cardiac amyloidosis using an ambulatory diuresis clinic

Reply to: Letter to the editor: Breaking the trend in cardiogenic shock-From door-to-balloon to door-to-support